Haemonetics Corporation (HAE) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Haemonetics Corporation on February 12, 2026. The report pertains to the publication of the Company's 2024-2025 Corporate Responsibility Report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a non-financial document and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing. The sole event reported is the release of the Corporate Responsibility Report.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies. The disclosed information regarding the Corporate Responsibility Report is explicitly stated not to be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings.
Investor Verification Checklist
- Verify the content of the 2024-2025 Corporate Responsibility Report via the Company's website.
- Confirm that this 8-K filing does not contain material financial updates or forward-looking guidance.
- Note that the disclosed information is exempt from Section 18 liabilities under the Exchange Act.